Menu
Urology & Andrology

Non-Muscle Invasive Bladder Cancer (NMIBC)

ICD-10 Code
C67.9

Clinical Criteria for Non-Muscle Invasive Bladder Cancer (NMIBC).

Clinical Presentation & Protocol

Patient Usually Complains Of

Patient presents with [gross/microscopic] hematuria, associated with [frequency/urgency/dysuria]. No history of flank pain or constitutional symptoms. Previous TURBT pathology confirms NMIBC, [Ta/T1], [low/high] grade. No prior history of BCG failure.

Clinical Examination Findings

Abdominal exam: Soft, non-tender, no palpable bladder distension or masses. External genitalia: Normal. Digital Rectal Exam (DRE): Prostate [size/consistency], no suspicious nodules. Lymph nodes: No palpable inguinal lymphadenopathy.

Treatment Protocol

Plan: 1. Repeat TURBT if indicated for staging. 2. Intravesical therapy: [BCG/Mitomycin C] induction course (6 weeks). 3. Maintenance therapy as per risk stratification. 4. Surveillance cystoscopy scheduled at [3/6/12] months.

Detailed clinical guide coming soon.